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In multiple sclerosis (MS), monoaminergic systems are altered as a result of both 
inflammation-dependent reduced synthesis and direct structural damage. Aberrant 
monoaminergic neurotransmission is increasingly considered a major contributor to fatigue 
pathophysiology. In this study, we aimed to compare the integrity of the monoaminergic white 
matter fibre tracts projecting from brainstem nuclei in a group of patients with MS (n=68) and 
healthy controls (n=34), and to investigate its association with fatigue. Fibre tracts integrity 
was assessed with the novel fixel-based analysis that simultaneously estimates axonal density, 
by means of ‘fibre density’, and white matter atrophy, by means of fibre ‘cross section’. We 
focused on ventral tegmental area, locus coeruleus, and raphe nuclei as the main source of 
dopaminergic, noradrenergic, and serotoninergic fibres within the brainstem, respectively. 
Fourteen tracts of interest projecting from these brainstem nuclei were reconstructed using 
diffusion tractography, and compared by means of the product of fibre-density and cross-
section (FDC). Finally, correlations of monoaminergic axonal damage with the modified 
fatigue impact scale scores were evaluated in MS. Fixel-based analysis revealed significant 
axonal damage – as measured by FDC reduction – within selective monoaminergic fibre-tracts 
projecting from brainstem nuclei in MS patients, in comparison to healthy controls; particularly 
within the dopaminergic-mesolimbic pathway, the noradrenergic-projections to prefrontal 
cortex, and serotoninergic-projections to cerebellum. Moreover, we observed significant 
correlations between severity of cognitive fatigue and axonal damage within the 
mesocorticolimbic tracts projecting from ventral tegmental area, as well as within the locus 
coeruleus projections to prefrontal cortex, suggesting a potential contribution of dopaminergic 
and noradrenergic pathways to central fatigue in MS. Our findings support the hypothesis that 
axonal damage along monoaminergic pathways contributes to the reduction/dysfunction of 
monoamines in MS and add new information on the mechanisms by which monoaminergic 
systems contribute to MS pathogenesis and fatigue. This supports the need for further research 







Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous 
system (CNS). The complex pathogenesis of MS is still largely unknown with respect to 
dysregulation of the immune system that pathologically targets the CNS myelin and 
oligodendrocytes. In recent years, the investigation of MS pathogenesis has focused on the 
reciprocal interactions between the immune and the nervous systems (Melnikov et al., 2018). 
Monoamines are crucial for these interactions due to their capability of binding to cell receptors 
of both the innate and adaptive immune system (Melnikov et al., 2020). Monoamines 
encompass three main types of neurotransmitters: dopamine, noradrenaline, and serotonin. In 
the brain, monoamine-producing neurons are located within the brainstem monoaminergic 
nuclei (BrMn) and project diffusely to the whole CNS, crucially regulating normal brain 
function (Bär et al., 2016). Dopaminergic (DA)-cells are located in the substantia nigra and 
ventral tegmental area (VTA) that are the origins of the nigrostriatal and mesocorticolimbic 
systems, respectively. The mesolimbic pathway comprises projections from the VTA to the 
nucleus accumbens (Nacc) and the limbic system (particularly hippocampus and amygdala), 
while the mesocortical system links the midbrain with the prefrontal cortex (PFC) and the rest 
of the neocortex (Bär et al., 2016; Ikemoto, 2007). Noradrenergic (NA)-fibres originate from 
the locus coeruleus (LC) and distribute throughout all the brain, with PFC receiving the largest 
contingent (Liu et al., 2017). The median and dorsal raphe nuclei (MR and DR) are the main 
source of serotoninergic (5HT)-cells within the brainstem. Their efferent projections reach all 
cortical areas (Hornung, 2003) and richly innervate the cerebellum (Oostland and van Hooft, 
2013). Monoaminergic systems are dysfunctional in many neurological and psychiatric 
diseases (Admon et al., 2017; Pavese et al., 2010; Serra et al., 2018), and represent the target 
for a large number of clinically efficacious drugs.   
Monoamines are key mediators of neuroimmune interaction and influence MS 
pathogenesis and course (Levite et al., 2017; Malinova et al., 2018; Manjaly et al., 2019; Polak 
et al., 2011). Both peripheral and CNS inflammation reduces monoamines’ synthesis and 
promotes a pro-inflammatory status in immune cells, increasing cytokine release and 
suppressing anti-inflammatory pathways (Cosentino et al., 2016; Melnikov et al., 2016). In 
addition to the direct effect of inflammation, brain monoamines in MS are reduced also as an 
indirect effect of structural damage. Brainstem is a major target of inflammation in MS and 
BrMn lesions are described with potential retrograde degeneration (Gadea, 2004; Polak et al., 
2011; Tortorella et al., 2006). Moreover white matter (WM) damage leads to axonal loss within 
monoaminergic fibre tracts, possibly altering/reducing monoaminergic transmission in MS and 
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causing a dysregulation of monoaminergic pathways (Gadea, 2004; Levite et al., 2017; Madsen 
et al., 2017; Malinova et al., 2018; Manjaly et al., 2019; Polak et al., 2011; Simonini et al., 
2010). The reduction/dysfunction of monoamines in MS may contribute to a wide range of 
clinical features typical of MS, such as fatigue, pain, and depression. Among them, fatigue is 
of particularly interest. Fatigue affects up to 80% of MS patients and represents one of the most 
debilitating symptoms (Heitmann et al., 2020; Manjaly et al., 2019). This is in part due to the 
fact that only few therapeutic options are available to alleviate the sensation of fatigue, ranging 
from pharmaceutical to non-pharmaceutical interventions (i.e. exercise, meditation and 
education) (Induruwa et al., 2012; Zielińska-Nowak et al., 2020). In general, there is a lack of 
consensus in treating MS fatigue, which might be attributable to deviations with regard to 
methods, MS populations and interventions. Moreover, one of the reasons for the difficulty in 
developing effective interventions is that, to date, the mechanisms underlying fatigue in MS are 
not completely understood (Manjaly et al., 2019; Zielińska-Nowak et al., 2020). Increasing 
evidence supports that altered monoaminergic neurotransmission and/or inflammation-induced 
decrease of neurotransmitter synthesis – with the consequent reduction of monoaminergic 
inputs supply to cortical/subcortical regions and the functional reorganisation of cortical 
networks – could contribute to MS fatigue (Dobryakova et al., 2015; Liu et al., 2017; Manjaly 
et al., 2019; Meeusen and Roelands, 2018; Pardini et al., 2010). In line with this monoaminergic 
hypothesis, two drugs currently used to treat fatigue in MS – amantadine and methylphenidate 
– are both DA-agonists (Zielińska-Nowak et al., 2020). 
In this study, we aimed to investigate structural damage within monoaminergic WM 
fibre pathways in MS, as compared to healthy controls (HC). Brainstem monoaminergic fibre 
tracts integrity was assessed by means of diffusion-MRI and tractography. To analyse 
diffusion-MRI data, we used the novel fixel-based analysis (FBA) which provides quantitative 
measures of macro- and microstructure associated with a single fibre population, even in voxels 
containing crossing fibres (Mito et al., 2018; Raffelt et al., 2017). FBA utilizes constrained 
spherical deconvolution (CSD) to estimate the fibre orientation distribution (FOD) within each 
voxel (Tournier et al., 2007) and identify the underlying fibre populations, called “fixels” 
(Raffelt et al., 2017, 2015). This is particularly important when reconstructing fibers originating 
from the BrMn, which are small compared to the typical resolution of diffusion-MRI. FOD 
amplitude is proportional to the apparent fibre density (FD) of axons aligned in that direction 
within a WM bundle when derived from high b-value diffusion-MRI data (Gajamange et al., 
2018; Raffelt et al., 2012). Through the non-linear FOD registration, FBA also provides 
information about the local morphology of WM tracts, called fibre cross-section (FC), which 
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reflects the volume perpendicular to the fibre orientation for each fibre population in a given 
voxel, not assessed with canonical approaches such as diffusion-tensor-imaging (Jeurissen et 
al., 2013). Finally, FD and FC values are multiplied to obtain the fibre density and cross-section 
(FDC) metric (FDC=FDxFC) that provides an overall picture of microstructural and 
macroscopic integrity across the WM tract. This has a fundamental importance in a disease like 
MS, where WM loss can result both from an alteration of intra-axonal volume of a fibre 
population within a voxel, and from axonal loss (atrophy) across the entire cross-section of the 
bundle (Gajamange et al., 2018; Ginsberg and Martin, 2002; Trapp and Stys, 2009). The 
contribution of macroscopic WM lesion load – particularly within the brainstem – and regional 
grey matter (GM) atrophy were also investigated by performing WM lesion probability maps 
and voxel-based morphometry, respectively. Finally, possible associations between 
monoaminergic fibre tracts axonal damage (as measured by FDC) and fatigue scores were 





Sixty-eight patients with relapsing-remitting-MS (RR-MS) (Thompson et al., 2018) and 
34 age- and sex-matched HC were recruited from the Brighton and Sussex Universities 
Hospitals Trust MS-clinic, UK. Patients were between 18 and 55 years-old and had an expanded 
disease status score (EDSS)<6.5 (Kurtzke, 1983). Exclusion criteria for patients were a history 
of other neurological diseases, psychiatric conditions and clinically significant disorders. Since 
mood and sleep disturbances may alter brainstem function, the Hospital Anxiety and 
Depression Scale (HADS-D) and the Epworth Sleepiness Scale (ESS) were used to exclude 
participants with evidence of depression and those likely to suffer from sleep disorders at the 
suggested cut-off of 11 and 10, respectively (Popp et al., 2017; Watson et al., 2014). MS 
patients were also screened for cognitive impairment, using the written version of the symbol 
digit modalities test of the brief International Cognitive Assessment for MS (Langdon et al., 
2012). Further exclusion criteria included steroid treatment or MS relapses within the previous 
4 weeks, as well as patients whose MS-treatment had been changed within that same interval. 
HC were between 18 and 70-year-old, without any significant medical disorders. Participants 
who had been on treatment with hypnotics within the last 4 weeks prior to their enrolment, on 
recreational drugs, or with a known alcohol abuse, were excluded.  
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Ethical approvals were obtained from the London-Surrey Borders Research Ethics 
Committee (REC reference 17/LO/0081) and the local BSMS-Research Governance and Ethics 
Committee (REC reference 14/014/HAR). Written informed consent was obtained from all 
participants before study initiation according to the declaration of Helsinki.  
 
2.2 Fatigue assessment 
Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS), a 21-item 
questionnaire that assesses impact on cognitive, physical, and psychosocial domains. The total 
MFIS score (MFIS-Tot; ranging 0-84) is computed by adding scores of the cognitive (MFIS-
Cog), physical (MFIS-Phys), and psychosocial (MFIS-PS) subscales (Flachenecker et al., 
2002). MFIS were administered to MS patients at visit 1 around 9-10 am, before neurological 
examination. 
 
2.3 MRI acquisition 
MRI was performed in MS patients at visit 2 around noon. Visits 1 and 2 have been not 
more than two weeks apart. MRI data were acquired in all participants on a 1.5T Siemens 
Magnetom Avanto scanner (Siemens Healthcare Solutions, Erlangen, Germany) equipped with 
a 32-channel head-coil at the Clinical Imaging Sciences Centre of the University of Sussex, 
UK. The full examination included: 1) 2D-Dual-echo turbo-spin-echo (TSE; TEs=11/86ms, 
TR=3040ms, echo-train-length=6, flip-angle=150°, FoV=220x192mm2; matrix=256x224; 
slice-thickness=5mm); 2) 2D-Fast fluid-attenuated inversion recovery (FLAIR; TE=87ms, 
TR=8000ms, TI=2500ms, flip-angle=150°, echo-train-length=17, same resolution as the dual 
echo); 3) 3D-Volumetric high-resolution T1-weighted magnetization prepared rapid gradient-
echo (MPRAGE; TE=3.57ms; TR=27.30ms; TI=100ms; flip-angle=70°; FoV=256x240mm2; 
matrix=254x40; slice-thickness=1mm); 4) 2D-2-shell diffusion-weighted pulsed-gradient spin-
echo EPI (TE=95ms, TR=4036, b values=800/2000s/mm2, number of diffusion 
directions=30/54, FoV=240x240mm2, matrix=96x96, slice-thickness=2.5mm, additional 9 
images with no diffusion weighting (b0) were acquired). Part of the b0 volumes were acquired 
with reversed gradient blips to enable correcting for susceptibility artefacts (Andersson and 
Sotiropoulos, 2016). The duration of the diffusion-weighted MRI scan was approximately 14 
minutes.  In addition, resting-state functional-MRI data and quantitative magnetization transfer 
imaging data were collected but are not included in the analysis presented here. In total, the 




2.4 FBA: pre-processing of data and FOD calculation 
FBA was performed using the MRtrix3 package (Brain Research Institute, Melbourne, 
Australia; http://mrtrix.readthedocs.io/en/latest). We followed the suggested processing which 
can be found at: 
https://mrtrix.readthedocs.io/en/latest/fixel_based_analysis/mt_fibre_density_crosssection.ht
ml (Tournier et al., 2019). Pre-processing steps include data denoising and Gibbs ringing 
removal that were performed using MRtrix3 (Tournier et al., 2019). The diffusion-MRI data 
were then corrected for susceptibility and eddy-current distortions, as well as for involuntary 
movement using the tools topup and eddy, available with the FMRIB Software Library (FSL, 
https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/eddy). Additionally, bias field correction was performed 
with MRtrix3 (Tournier et al., 2019). Data were upsampled to a voxel size of 1.25 mm isotropic 
to increase anatomical contrast and improve the downstream steps of template building, 
registration, tracking, and statistics. After the pre-processing, for each subject a whole-brain 
mask was defined and a FOD was computed from the highest b-value only (b=2000s/mm2) 
using the Dhollander method (Dhollander T, Raffelt D, Connelly A, 2016). We chose to select 
only this b-value to avoid any potential extra-axonal signal contribution (Genc et al., 2020), as 
previously done in other studies (Dimond et al., 2020). The Dhollander method is designed to 
rely on multi-tissue CSD even in absence of multi-shell data (Dhollander T et al., 2019). Each 
subjects’ mask was visually inspected to check whether all brain regions intended to be 
analysed were included. A population-averaged FOD template was generated combining the 
FODs from a representative subset of subjects in a midway space (20 MS-patients and 20 HC, 
randomly chosen), and then non-linearly registering the FOD of each subject (including the 
ones in the initial subset) to the template (Raffelt et al., 2012, 2011). Masks were warped to 
template space and the template was filtered using the intersection of all the subjects’ masks in 
template space. Fixels were then segmented from the FOD template, generating the fixel 
template mask used in the subsequent statistical analyses (Raffelt et al., 2015). 
 
2.5 Fixel-based metrics 
FD, FC, and FDC were calculated for each subject across all WM fixels in the fixel 
template mask. FD was mapped for each subject directly from the template space as the integral 
of the FOD. A reduced FD may indicate fewer axons in a fixel, and therefore potential WM 
microstructural damage. The Jacobian determinant of the deformation field generated from the 
registration of each subject’s FOD map to the FOD template was used to obtain the FC metric. 
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FC values higher than 1 indicate a larger FC in the participant as compared to the reference 
FOD template, while FC values lower than 1 indicate a smaller FC that may result from 
impaired axonal growth or atrophy after neuronal damage. In order to ensure that FC data were 
centred around zero and normally distributed, we used the natural logarithm of FC for group 
comparisons. FD and FC were finally multiplied by each fixel to obtain FDC values 
(FDC=FDxFC) (Raffelt et al., 2017). 
 
2.6 Tract of interest analysis 
A tract of interest analysis was conducted to investigate alterations in specific DA, NA, 
and 5HT fibre tracts (Fig.1). WM tracts between selected regions of interest (ROI) were 
probabilistically reconstructed using the iFOD2 algorithm implemented in MRtrix3, using the 
appropriate parameters to obtain results in line with the expected anatomy of each pathway. 
Tractography was performed from every voxel included in the seed regions. Tracts were then 
identified by imposing that each tract should either cross or reach other specified regions. These 
regions (as detailed in Supplementary Table 1) were chosen based on prior anatomical 
knowledge which have been supported by existing literature (Coenen et al., 2018; Counts and 
Mufson, 2012; Englot et al., 2018; Kline et al., 2016; Liu et al., 2017). Exclusion criteria by 
means of tailored ROI were used. ROI were created using the Harvard-Oxford cortical and 
structural atlases for cortical and subcortical structures, and the Probabilistic Atlas of the 
Human Cerebellum for cerebellar cortex, both distributed with FSL (Desikan et al., 2006; 
Diedrichsen et al., 2009). The atlases were aligned to the population template using a non-linear 
transformation estimated with the ANTs software package (http://stnava.github.io/ANTs/): 
first, we estimated a non-linear transformation using the 1 mm MNI template as the fixed image 
and the spherical harmonic of order l=0 from the FOD as the moving image (using the default 
parameters); then, we applied the inverse warp (from MNI to the FOD template) to align the 
ROIs to the population template. It is important to note that, although the volume of the BrMn 
is small, the tractography approach we have chosen, which allows multiple directions per voxels 
and uses a priori anatomical knowledge, limits the risk of including unwanted tracts in the 
analyses. Examples of tracts’ reconstruction are provided in Fig.2. 
In detail, we reconstructed the two major efferent DA-projections originating from VTA: 
the mesolimbic (through which DA projections target the Nacc, amygdala, and hippocampus) 
and the mesocortical pathway (through which DA projections target the PFC) (Bär et al., 2016; 
Kandel, E. R., Schwartz, J. H., & Jessell, T. M., 2000). VTA projections ascend the midbrain 
and converge in basal forebrain in the dorsal portion of the medial forebrain bundle (MFB), 
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through which DA-axons reach the limbic system and the PFC, over the anterior limb of the 
internal capsule (aIC). We reconstructed these WM tracts and further subdivided them into 
three different mesolimbic (VTA-Nacc, VTA-amygdala, and VTA-hippocampus) and three 
mesocortical bundles (VTA-dorsolateral(dl)PFC, VTA-medial orbitofrontal(mOf)PFC, and 
VTA-lateral orbitofrontal(lOf)PFC). For NA pathways, we reconstructed the major efferent 
bundle connecting the LC to the PFC, which ascends the midbrain ventrally, prosecutes in the 
dorsal portion of the MFB (with DA-neurons), and reaches the PFC over the aIC (Benarroch, 
2009; Kandel, E. R., Schwartz, J. H., & Jessell, T. M., 2000). PFC projections were divided 
into three different bundles (LC-dlPFC, LC-mOfPFC, and LC-lOfPFC). Given the wide-spread 
5HT innervation of the CNS, we decided to focus on the specific 5HT fibre-tracts projecting 
from the raphe nuclei to two different cerebellar cortex regions: the lobules V-VI – functionally 
connected with sensory-motor areas – and the lobule VII (encompassing the Crus I, Crus II, 
and the lobule VIIb), functionally connected with PFC and posterior-parietal cortex (O’Reilly 
et al., 2010). We reconstructed distinct tracts originating from DR and MR to reach the 
cerebellar lobules of interest (V-VI and VII) in two separate bundles, through the superior and 
middle cerebellar peduncle, respectively (Hornung, 2003; Oostland and van Hooft, 2013). A 
schematic of the fibre tracts that have been analysed is provided in Fig.1. Finally, for the 
purpose of validating the method of reconstruction, we chose to study the cingulum as a 
representative WM fibre tract that is anatomically well-characterized and not primary 
structurally connected with the brainstem monoaminergic projections. In summary, the 
following 14 tracts were reconstructed: VTA-Nacc; VTA-amygdala; VTA-hippocampus; VTA-
dorsolateral(dl)PFC; VTA-medial orbitofrontal(mOf)PFC; VTA-lateral orbitofrontal(lOf)PFC; 
LC-dlPFC; LC-mOfPFC; LC-lOfPFC; MR-Cerebellar Lobule V-VI; MR-Cerebellar Lobule 
VII; DR-Cerebellar lobule V-VI; DR-Cerebellar lobule VII; cingulum. Averaged FD, FC, and 
FDC were calculated across the fixels in each tract in MS patients and HC.  
 
2.7 WM lesion identification and probability lesion map 
WM macroscopic lesions were identified on FLAIR scans by consensus between two 
observers and measured by using a local thresholding segmentation technique (Jim Image 
Analysis Package; Xinapse Systems, Leicester, UK). T2-weighted scans were used to increase 
confidence in lesion identification. Binary lesion maps were computed and warped into 1mm 
MNI space using ANTs. Lesion maps were then averaged across patients to yield a probability 
map where each voxel value represents the proportion of patients having a lesion in that given 
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voxel. For example, a value of 0.3 indicates that 30% of our cohort had a lesion in that specific 
location. 
 
2.8 Regional GM atrophy 
Every participant’s MPRAGE was visually inspected to exclude macroscopic artefacts 
and segmented in Statistical Parametric Mapping 12 (SPM12; Wellcome Department of 
Imaging Neuroscience; www.fil.ion.ucl.ac.uk/spm) to obtain participant-specific GM, WM and 
CSF maps, as well as the total intracranial volume (TIV). Data were processed using an 
optimized VBM protocol (Ashburner and Friston, 2005; Good et al., 2001). Segmentation and 
normalization produced a GM probability map in Montreal Neurological Institute (MNI) 
coordinates. To compensate for compression or expansion during warping of images to match 
the template, GM maps were modulated by multiplying the intensity of each voxel by the local 
value derived from the deformation field. All data were then smoothed using a 8-mm full width 
half maximum Gaussian kernel. Regional differences in GM volume between HC and MS 
patients were assessed, with age, gender, and TIV as covariates of no interest. All analyses were 
conducted with SPM12 and tested at p<0.05 family-wise-error (FWE), corrected at peak level. 
  
2.9 Statistical analyses 
SPSS-Statistics-v25.0 (SPSS Inc., Chicago, USA), and PRISM-v6.0 (GraphPad, San 
Diego, USA) were used for statistical analyses. Between-group comparisons of demographic 
variables were tested with Mann-Whitney U tests or chi-square tests, as appropriate, setting 
p<0.05. FBA results were represented as the mean FD/FC/FDC and standard deviation (SD) in 
MS-patients and HC. FC data are expressed as logarithm of FC values (logFC) to ensure that 
data were centred around zero and normally distributed. Comparison between groups was tested 
with independent-sample t-tests, setting p<0.003 after Bonferroni correction for multiple 
comparisons (14 tracts: α=0.05/14=0.00357143). Correlations between FDC and MFIS-Cog, 
MFIS-Phys and total MFIS scores were performed assessing the Pearson’s correlation 
coefficient. We did not tested correlations between FDC and MFIS-PS due to lack of data in 
literature and difficulties in the interpretation of results concerning this subscale (Kos et al., 
2005). As MFIS is computed as the sum of the subscores, and therefore is not independent, 
Bonferroni correction for multiple comparisons was applied considering 2 independent tests 






3.1 Participants’ characteristics 
The main characteristics of the included population are summarized in Table 1. There 
were no significant differences between groups in age/gender distribution. Fifty-two of the 
recruited MS patients were on disease-modifying treatment (See Table 1 for details), and 3 
were under fatigue-treatment with amantadine for at least 5 years, with only 1 patient referring 
beneficial in alleviating fatigue.  
 
3.2 FBA 
Table 2 provides a detailed list of FBA results. Mesocorticolimbic DA-pathway was 
investigated. FBA revealed FDC reduction in the fibre tracts between VTA and Nacc, amygdala, 
and hippocampus in MS patients, compared to HC (Fig. 3). Notably, the VTA-Nacc projection 
showed a reduction in both FD and FC. Conversely, FC was the only parameter reduced in the 
VTA-amygdala tract, and FD the only one reduced in the VTA-hippocampus tract. No 
significant difference in fixel metrics was observed in the tract between VTA and PFC between 
patients and HC, except for a slight reduction of FDC in the DA projections to lOfPFC and – 
to a minor extend – mOfPFC.  
Projections from LC to PFC were investigated. A loss of FC and FDC within all fibre tracts 
connecting LC to PFC was found in MS patients, as compared to HC (Fig. 4). The LC-mOfPFC 
tract also showed lower FD values. 
As concerns 5HT fibres, projections from the raphe nuclei to the cerebellar cortex were 
studied. FBA showed lower FDC in the tracts connecting both DR and MR to the cerebellar 
lobules V-VI and VII in MS patients, as compared to HC (Fig. 5), whereas no difference in 
average FD was found within the same tracts between the two groups. DR and MR projections 
to cerebellar lobules V-VI also showed reduced FC. 
Although not reaching the statistical significance, FBA revealed that FC and FDC within 
the cingulum were reduced in MS patients, as compared to HC (Supplementary Fig.1). 
 
3.3 WM-lesion incidence and regional GM atrophy 
The highest lesion incidence (>20%) was observed in the periventricular non-callosal-
WM that includes the anterior, middle and posterior corona radiata, as well as in the thalamic 
radiation. Lesion frequency in the brainstem across all patients was less than 2% (i.e. only 1 out 
of 68 MS patients had visible brainstem WM lesions; Fig. 6). This suggests that the observed 
reductions in FBA-derived parameters are more likely to be explained by subtle axonal 
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degeneration and loss than by macroscopic lesions located within the BrMn. VBM analyses 
revealed no significant difference in global GM volume between MS patients and HC 
(mean±SD: 661.2±67.0 vs 686.4±69.9). When compared to HC, patients showed a significant 
regional GM loss in the thalamus bilaterally (pFWE<0.0001; Supplementary Fig.2). 
 
3.4 Associations between monoaminergic fibre-tract axonal loss and MS-fatigue  
BrMn axonal damage (by means of FDC reduction) was moderately associated with 
cognitive fatigue in MS. Particularly, MFIS-Cog inversely correlated with almost all the 
analysed DA tracts originating from VTA [Nacc (r=-0.28; p=0.021), amygdala (r=-0.29; 
p=0.017), hippocampus (r=-0.36; p=0.002), mOfPFC (r=-0.25; p=not-significant), and lOfPFC 
(r=-0.30; p=0.014)]. Moreover, we found an inverse correlation between MFIS-cog and FDC 
within the LC-PFC tract [dlPFC (r=-0.29; p=0.017) and lOfPFC (r=-0.28; p=0.019)], but not 
within the WM tracts from DR/MR to cerebellar cortex, except a moderate correlation in the 
tract connecting MR to cerebellar-lobule VII (r=-0.27; p=0.025). No associations were found 
between FDC within all the analysed WM tracts and both MFIS-Tot and MFIS-Phys, except 
for a significant inverse correlation between FDC within the DA VTA-hippocampus tract and 
the MFIS-Tot score (r=-0.32, p=0.008). FDC within the cingulum resulted inversely correlated 
with MFIS-Cog (r=-0,34; p=0.004), as previously described (Bisecco et al., 2016). All 
correlation data are provided in Supplementary Table 2. 
 
4. Discussion 
The monoaminergic neurotransmitters dopamine, noradrenaline, and serotonin have a 
pivotal role in the interplay between the nervous and the immune system and are crucial 
regulators of normal brain function. Emerging evidence supports a dysregulation of 
monoaminergic systems in the pathogenesis of MS, secondary to both inflammation-induced 
reduction of monoamines’ synthesis and structural damage to monoaminergic pathways within 
the brain. Only few studies have provided evidence of a structural damage of BrMn in MS 
(Polak et al., 2011), owning to the small dimension of the brainstem and its proximity to large 
arteries and ventricles. An indirect measure of monoaminergic structural damage in MS has 
been obtained with resting-state functional-MRI, by detecting functional disconnection 
between BrMn and other brain areas. Carotenuto et al. recently reported increased functional-
connectivity between the dorsal raphe and the PFC, decreased functional-connectivity between 
the VTA and the PFC, and decreased betweenness centrality (a measure of the importance of a 
given node within a network) for the brainstem in MS patients, as compared to HC. These 
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findings suggest a damage in the ascending projections from BrMn in MS with a reduced 
activity in controlling the cortical regions of monoaminergic brain networks (Carotenuto et al., 
2020). Similarly, by using proton-MRI-spectroscopy, Gadea et al. reported a reduction of N-
acetyl-aspartate/creatine ratio in the pontine normal-appearing WM of a group of early RR-MS 
patients, possibly representing an indirect measure of structural damage of LC cells or its 
projections (Gadea, 2004). 
Against this background, our study aimed to investigate whether these changes in 
functional connectivity are underpinned by a loss of structural connectivity. Specifically, we 
set out to evaluate the sensitivity of FBA-metrics (FD, FC, and FDC) as markers for axonal loss 
within specific DA, NA, and 5HT fibre-tracts in MS patients and HC. FBA has been recently 
applied in different pathologic conditions (Lyon et al., 2019; Mito et al., 2018; Pecheva et al., 
2019; Raffelt et al., 2017). In MS, FBA was used by Gajamange et al. in a cohort of early MS 
patients with acute optic neuritis, finding reductions in fixel-based metrics in the visual 
pathway, as compared to HC (Gajamange et al., 2018). When comparing FBA to conventional 
diffusion-tensor imaging analysis, these Authors found a comparable sensitivity of FD and 
fractional anisotropy in detecting WM pathology in MS, but greater specificity for axonal 
density, higher sensitivity to damage in multiple fibre populations within a voxel, simultaneous 
measurement of microstructural and macroscopic neurodegenerative changes (Gajamange et 
al., 2018). This additional comprehensive analysis is precious in diseases like MS, where axonal 
damage within a given fibre-tract results from multiple factors, such as direct inflammatory 
injury with axonal transection and Wallerian retrograde degeneration; excitotoxicity-generated 
secondary axonal degeneration in denuded chronically-demyelinated axons; trans-synaptic 
degeneration resulting from the loss of afferent inputs or efferent targets (Gajamange et al., 
2018; Ginsberg and Martin, 2002).  
FBA revealed significant axonal damage within monoaminergic fibre-tracts projecting 
from BrMn in MS patients, in comparison to HC. The features of WM damage are different 
across individual tracts. As expected, considering that FD and FC are derived from two separate 
sources of information (diffusion signal and nonlinear transformation field respectively), the 
multiplication of their effects as FDC enabled an overall measure of fibre changes and provided 
the most significant data (Raffelt et al., 2017). Some fibre tracts (VTA projection to Nacc and 
LC projections to mOfPFC) demonstrated both microstructural alterations in FD and 
macrostructural alterations in FC, revealing a pronounced structural disconnection between 
these BrMn and their cortical and subcortical efferent targets. VTA-hippocampus projections 
showed microstructural FD reduction, without substantial concomitant morphological 
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alterations within the fibre tract, suggesting that axonal loss occurs mainly at a microstructural 
level. Conversely, VTA projections to amygdala, LC projections to dlPFC and lOfPFC, raphe 
nuclei projections to cerebellar lobule V-VI, and PPN projections to cerebellar lobule V-VI 
displayed fibre tract-specific atrophy (as indexed by the FC metric), without changes in FD. 
Similarly, VTA-PFC projections showed a more substantial reduction in FC rather than both 
FD and FDC. This finding denotes a scenario where a difference in a fibre bundle's intra-axonal 
volume is manifested as a difference in the number of voxels that the fibre bundle occupies 
(Raffelt et al., 2017). It should be noted that from our analysis it seems that the macroscopic 
axonal loss (as expressed by FC) outweighs microscopic changes (as indicated in FD), and that 
FDC largely reflects FC. In summary, as concerns DA projections from VTA, MS patients 
showed significant axonal damage in the mesolimbic pathway, particularly in the fibre-tract 
targeting Nacc. The mesocortical tract displayed reduction in WM in MS patients in comparison 
of HC, although the difference did not reach statistical significance. This suggests a 
predominant involvement of the mesolimbic pathway in MS, as compared to the mesocortical 
pathway, that could be linked to topographical reasons, i.e. the preferential involvement of MS 
lesions for the deep periventricular WM/temporal horn of lateral ventricle (Arrambide et al., 
2017). NA fibres projecting from LC to PFC showed in MS a significant WM reduction within 
all bundles taken into consideration, as compared to HC. Finally, MS patients displayed 
significant axonal damage within the 5HT fibre tracts from raphe nuclei targeting cerebellar 
lobules V-VI and from MR targeting cerebellar lobule VII. Taken all together, these results 
showed a disruption of brainstem monoaminergic fibre tracts integrity in MS, secondary to 
microscopic and/or macroscopic axonal loss. Only 1 out of 68 MS patients had visible 
macroscopic WM brainstem lesions, suggesting that local macroscopic lesions do not 
significantly contribute to our results. It should be noted, however, that the FLAIR acquisition 
had a slice thickness of 5mm, and therefore it is possible that we have missed some small 
brainstem lesions. Within this limitation, the prevalence of macroscopic WM lesions within the 
brainstem was too low to have an influence on fatigue. We have also assessed the pattern of 
GM loss, in order to establish its anatomical relationship with the WM pathways studied here. 
VBM showed a significant difference in GM volume between MS patients and HC only in 
bilateral thalamus, as already described (Bisecco et al., 2016; Filippi and Rocca, 2011).  
Therefore, regional GM atrophy is unlikely to contribute to axonal damage as assessed in this 
study. 
Our study revealed also a moderate correlation between structural integrity within DA- 
and NA-WM tracts and the MFIS-cog, suggesting a link between structural damage within the 
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mesocorticolimbic and LC-PFC pathways and severity of central MS fatigue. Central fatigue is 
common in MS and is qualitatively different from peripheral fatigue, which primarily affects 
physical exercise, sparing mental processes (Arm et al., 2019). Our results are consistent with 
previous literature sustaining a role of aberrant monoaminergic – particularly DA – 
neurotransmission in the pathophysiology of MS fatigue (Dobryakova et al., 2015; Manjaly et 
al., 2019). Structural WM damage within monoaminergic pathways or inflammation-induced 
decrease of monoamines synthesis could explain the reduction in motivation, mood and arousal 
that characterize fatigue. Moreover, two drugs that are currently used to treat fatigue in MS – 
amantadine and methylphenidate – are both DA-agonists. Only 3 of the patients include in this 
study were under treatment with amantadine for fatigue (for a long-time). Although this could 
be seen as a confound in our analysis, the small number of patients who had been taking 
amantadine suggests that such an effect should be negligible. The dopamine imbalance 
hypothesis of fatigue in MS is supported by several imaging studies showing the presence of 
both structural and functional alterations within the mesocorticolimbic pathways of MS patients 
experiencing fatigue (Dobryakova et al., 2015; Genova et al., 2013; Pardini et al., 2010). 
Recently, Chen et al. demonstrated by using functional-MRI altered cognitive fatigue-related 
functional connectivity in the monoamine-associated interoceptive and reward pathways in MS 
and speculated that such alterations may be the result of inefficient brain connectivity when 
meeting increased task demands (Chen et al., 2020). Similarly, Jaeger et al performed a sub-
region functional-MRI analysis finding that MS-related fatigue was associated with impaired 
functional connectivity of the striatum with sensorimotor, attention, and reward networks. 
Authors suggested the superior ventral striatum as the key integrational hub impaired in MS-
related fatigue (Jaeger et al., 2019). Our data suggests a potential role of both dopamine and 
noradrenaline in the pathogenesis of MS fatigue that needs to be further investigated in future 
studies. Finally, although alterations of the 5HT system have been associated to fatigue 
(Dobryakova et al., 2015; Hesse et al., 2014), we did not report significant correlation (except 
for a trend toward significance in the tract connecting MR to cerebellar-lobule VII), possibly 
due to the fact that we only investigated those bundles originating from raphe nuclei and 
projecting to the cerebellar cortex.  
Some limitations should be disclosed. First, the definition of BrMn using a standard space 
(MNI) atlas (due to the difficulties in identifying each nucleus on subject specific MRI) is less 
accurate than registering the standard ROI to each participant’s scan and that BrMn’ 
macroscopic atrophy might have affected our results (Serra et al., 2018). Nevertheless, it is not 
possible to measure each nucleus-volume independently to adjust for this potential confound. 
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A related point are the well-known limitations of tractography (Jones et al., 2013; Jones and 
Cercignani, 2010), especially in terms of potential false positives in the reconstructed tracts 
(Maier-Hein et al., 2017). To reduce this issue, a recent work has showed using an animal model 
how tractography can be highly accurate if one relies on prior anatomical knowledge (Schilling 
et al., 2020): in this direction, we leveraged anatomy to define constraints on a pathway-by-
pathways basis and ultimately to reconstruct known connections of the brainstem nuclei. With 
respect to the interpretation of results, although we did not identify a significant amount of 
macroscopic lesions within the brainstem, we can not exclude that microstructural WM damage 
within the brainstem might have contributed to fatigue in our cohort of MS patients. The lack 
of fatigue and other clinical assessments in the control group could also be seen as a limitation 
and might have influenced our findings. However, HC were included only if they did not have 
any significant medical issue, and no neurological, psychiatric, and sleep disturbances. Fatigue 
is a pathological symptom that can be present in different diseases, especially inflammatory 
disorders, but it is not supposed to be present in the healthy population. Moreover, we are aware 
that mood and sleep disturbances may contribute to fatigue and be influenced by 
monoaminergic dysfunction in MS. For these reasons, we decide to exclude from the study all 
participants with evidence of depression and those likely to suffer from sleep disorders, by 
using specific validated scales (HADS-D and ESS). Moreover, the partial correlations between 
FDC and fatigue scores, controlling for depression and sleep disturbances (i.e. the individual 
scores of HADS-D and ESS) showed the same significant data (Supplementary Table 3). 
Similarly, all correlations between age and all MFIS scores did not show any significant 
association (all p>0.05). Although the study was designed to perform all the assessments at the 
same time of day for all participants, in some cases it was not possible to stick to rigid timing 
because it very much depended on people's availability. However, we should stress that this 
happened in a minority of cases, and anyhow we were mainly interested in trait fatigue, rather 
than state fatigue, which should not be affected too badly by time of assessment. Finally, the 
present study has a cross-sectional design. Longitudinal studies are needed to analyse the 
contribution of monoamines to MS pathogenesis and the relationship between monoaminergic 
pathways and fatigue modifications in MS. 
 
4.1 Conclusions 
In conclusion, we have first used FBA to detect reduction of FDC within specific 
monoaminergic fibre tracts projecting from BrMn in MS, particularly within the DA-
mesolimbic pathway, NA-projections to PFC and 5HT-projections to cerebellum. These 
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findings support the hypothesis that axonal damage along monoaminergic pathways contributes 
to the reduction/dysfunction of monoamines in MS and add new information on the 
mechanisms by which monoaminergic systems contribute to MS pathogenesis. Moreover, our 
study supports the hypothesis of a major contribution of the DA-mesocorticolimbic pathway to 
central fatigue in MS, and suggests a potential implication of the NA-LC-PFC pathway, 
possibly due to axonal loss that imbalances DA and NA neurotransmission. Although the 
relationship between aberrant monoaminergic neurotransmission and axonal loss in MS needs 
to be further clarified, our data support the need for further research into monoamines as 
potential therapeutic targets aimed to combat and alleviate fatigue in MS. 
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Fig. 1 Main dopaminergic (left), noradrenergic (centre), and serotoninergic (right) pathways 
within the human central nervous system (top) and schematic of the monoaminergic 
connections that have been analysed in this study by tract of interest analysis (bottom). The 
colors of the different regions in the bottom are used in the later figures for the same regions. 
Figure was created with BioRender.com (SN = substantia nigra; VTA = ventral tegmental area; 
DS = dorsal striatum; Nacc = nucleus accumbens; Hippoc = hippocampus; Amygd = amygdala; 
dl-PFC = dorsolateral prefrontal cortex; Of-PFC = orbitofrontal-PFC; LC = locus coeruleus; 
MR = median raphe; DR = dorsal raphe). 
 
Fig.2 Intermediate steps for sample tracts (left: cingulum; centre: locus coeruleus- dorsolateral 
prefrontal cortex; right: median raphe-cerebellar lobule VII). A) the tractogram reconstructed 
using the inclusion and exclusion criteria described in Supplementary Table 1; B) the related 
mask defined using an appropriate threshold; C) the related fixels representing the underlying 
fiber populations (P = posterior, R = right, LC = locus coeruleus, dlPFC = dorsolateral 
prefrontal cortex; MR = median raphe, Cer = cerebellar). 
 
Fig. 3 Mesocorticolimbic fibre tract-specific significant FDC decreases in patients with 
multiple sclerosis (RR-MS) compared to healthy control (HC). Tracts of interest projecting 
from ventral tegmental area (VTA) are shown in glass brain representations using the mrview 
tool in MRtrix3. A) mesolimbic pathway encompasses the tracts connecting VTA with nucleus 
accumbens, amygdala, and hippocampus; B) mesocortical pathway encompasses VTA 
projections to medial and lateral orbitofrontal and dorsolateral prefrontal cortex (PFC). 
Differences in average FDC between HC and RR-MS patients in the selected white matter tracts 
of the A) mesolimbic and B) mesocortical pathway are shown in scatter plots. Comparisons 
were tested by independent sample t-tests. The statistical threshold was set to p<0.003 after 
Bonferroni correction for multiple comparisons (FDC = fibre-density cross-section, A = 
anterior, L = left). 
 
Fig. 4 Locus coeruleus-prefrontal cortex fibre tract-specific significant FDC decreases in 
patients with multiple sclerosis (RR-MS) compared to healthy control (HC). Tracts of interest 
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projecting from locus coeruleus (LC) to medial and lateral orbitofrontal and dorsolateral 
prefrontal cortex (PFC) are shown in glass brain representations using the mrview tool in 
MRtrix3. Differences in average FDC between HC and RR-MS patients in the selected white 
matter tracts of the LC-PFC tracts are shown in scatter plots. Comparisons were tested by 
independent sample t-tests. The statistical threshold was set to p<0.003 after Bonferroni 
correction for multiple comparisons (FDC = fibre-density cross-section, A = anterior, L = left, 
R = right). 
 
Fig. 5 Raphe nuclei-cerebellar cortex fibre tract-specific significant FDC decreases in patients 
with multiple sclerosis (RR-MS) compared to healthy control (HC). Tracts of interest projecting 
from A) median raphe (MR) and B) dorsal raphe (DR) to cerebellum are shown in glass brain 
representations using the mrview tool in MRtrix3. Differences in average FDC between HC and 
MS patients in the selected white matter tracts from raphe nuclei to cerebellar lobules V-VI and 
VII are shown in scatter plots. Comparisons were tested by independent sample t-tests. The 
statistical threshold was set to p<0.003 after Bonferroni correction for multiple comparisons. 
(FDC = fibre-density cross-section, A = anterior, P = posterior, L = left, R = right). 
 
Fig. 6 White matter lesions probability map in MS patients. Each participant’s lesion maps 
were averaged to yield a lesion probability map where each voxel value represents the 
probability of it being a lesion (expressed as percentage). Results are superposed on the MNI-










Main demographic and clinical characteristics of the included population. 
 RR-MS HC p 
n 68 34  
Age, years, mean±SD 43.3±7.7 43.9±15.9 0.78 
Female, number (percentage) 43 (63.2) 19 (55.9) 0.47 
Disease duration, years, mean±SD 7.4±6.5   
EDSS, median (1st-3rd quartiles) 1.5 (1.0-3.0)   
MS-specific treatment, number (percentage)    
  No treatment 16 (23.5)   
  First line DMTs 25 (36.8)   
  Second line DMTs 27 (39.7)   
MFIS-Tot, median (1st-3rd quartiles) 34.5 (24.5-47.0)   
  MFIS-Cog 16.0 (11.0-20.0)   
  MFIS-Phys 16.7 (10.0-23.0)   
  MFIS-PS 3.0 (1.0-4.0)   
SDMT, median (1st-3rd quartiles) 49.0 (48.2-64.7)   
HADS-D, median (1st-3rd quartiles) 1.5 (1.0-4.0)   
ESS, median (1st-3rd quartiles) 4.0 (2.0-6.2)   
 
[Abbreviations = RR-MS: Relapsing-Remitting Multiple Sclerosis; HC: Healthy Controls; SD: standard deviation; 
EDSS: Expanded Disability Status Scale; DMTs: Disease Modifying Therapies; MFIS: Modified Fatigue Impact Scale; 
Tot: total score; Cog: cognitive subscale; Phys: physical subscale; PS: psychosocial subscale; SDMT: Symbol Digit 
Modalities Test; HADS-D: Hospital Anxiety Depression Scale; ESS: Epworth Sleepiness Scale.] 
 
Table 2 
Average values of fibre density (FD), fibre cross-section (FC), and fibre density and cross-section 
(FDC) in the selected fibre tracts in relapsing-remitting multiple sclerosis (RR-MS) patients and in 
healthy controls (HC). Data are reported as mean ± standard deviation. Statistical threshold was set 
to p<0.003 after Bonferroni correction for multiple comparisons. *FC data are expressed as 
logarithm of FC values (logFC) to ensure that data were centred around zero and normally 
distributed.  
 
Tract FD logFC* FDC 
 RR-MS HC p RR-MS HC p RR-MS HC p 
VTA-Nacc 0.34±0.02 0.36±0.03 <0.0001 0.02±0.08 0.09±0.07 0.0001 0.35±0.04 0.40±0.06 <0.0001 
VTA-amygdala 0.38±0.02 0.40±0.03 0.006 -0.01±0.06 0.05±0.06 <0.0001 0.39±0.04 0.43±0.06 <0.0001 
VTA-
hippocampus 0.32±0.04 0.35±0.03 0.0004 -0.01±0.09 0.03±0.07 0.07 0.31±0.04 0.36±0.04 <0.0001 
VTA-dlPFC 0.33±0.02 0.33±0.01 0.83 0.04±0.10 0.09±0.10 0.06 0.35±0.04 0.37±0.05 0.07 
VTA-mOfPFC 0.39±0.02 0.39±0.03 0.74 0.05±0.09 0.10±0.08 0.003 0.42±0.05 0.45±0.06 0.02 
VTA-lOfPFC 0.41±0.02 0.42±0.03 0.07 0.04±0.10 0.10±0.09 0.003 0.43±0.05 0.47±0.07 0.003 
LC-dlPFC 0.48±0.02 0.49±0.03 0.05 0.02±0.09 0.08±0.08 0.001 0.49±0.06 0.54±0.07 0.0009 
LC-mOfPFC 0.49±0.02 0.51±0.03 0.0009 0.02±0.08 0.10±0.08 <0.0001 0.50±0.06 0.57±0.07 <0.0001 
LC-lOfPFC 0.45±0.02 0.46±0.03 0.007 0.03±0.08 0.09±0.08 0.0001 0.46±0.05 0.51±0.06 <0.0001 
MR-Cer Lob 
VII 0.38±0.01 0.38±0.02 0.42 0.10±0.09 0.16±0.10 0.007 0.42±0.05 0.46±0.06 0.001 
MR-Cer Lob 
V+VI 0.35±0.01 0.36±0.01 0.06 0.06±0.08 0.12±0.08 0.001 0.39±0.05 0.43±0.05 0.0002 
DR-Cer Lob VII 0.35±0.02 0.35±0.02 0.80 0.05±0.08 0.10±0.09 0.005 0.36±0.04 0.39±0.04 0.004 
DR-Cer Lob 
V+VI 0.35±0.02 0.35±0.02 0.49 0.02±0.07 0.08±0.08 0.001 0.35±0.03 0.38±0.04 0.0004 
Cingulum 0.34±0.02 0.34±0.02 0.07 0.01±0.10 0.07±0.09 0.005 0.35±0.05 0.37±0.05 0.08 
 
[Abbreviations: VTA: ventral tegmental area; Nacc: nucleus accumbens; dlPFC: dorsolateral prefrontal cortex; mOfPFC: 
medial orbito-frontal prefrontal cortex; lOfPFC: lateral orbito-frontal prefrontal cortex; LC: locus coeruleus; Cer Lob: 







Supplementary Table 1: Tractograms generated using MRtrix. All probabilistic 
tractographies were performed unidirectionally, with minimum length of 10 mm and 
maximum length of 250 mm.  We used exclusion criteria by means of tailored region of 
interest (ROI) that were created using the Harvard-Oxford cortical and structural atlases for 
cerebral cortex and subcortical structures [17], and the probabilistic atlas of the human 
cerebellum for cerebellar cortex [18], both distributed with FMRIB Software Library (FSL). 
The following 14 tracts were reconstructed: ventral tegmental area (VTA)-Nucleus 
accumbens; VTA-amygdala; VTA-hippocampus; VTA-dorsolateral(dl) prefrontal cortex 
(PFC); VTA-medial orbitofrontal(mOf)PFC; VTA-lateral orbitofrontal(lOf)PFC; locus 
coeruleus (LC)-dlPFC; LC-mOfPFC; LC-lOfPFC; median raphe (M)R-Cerebellar Lobule V-
VI; MR-Cerebellar Lobule VII; dorsal raphe (DR)-Cerebellar lobule V-VI; DR-Cerebellar 
lobule VII; cingulum. Averaged FD, FC, and FDC were calculated across the fixels in each 








VTA-Nacc 20° 100 PFC, PCC, corpus callosum 
VTA-amygdala 20° 100 Temporal lobe, hippocampus 
VTA-hippocampus 20° 100 Temporal lobe, amygdala 
VTA-dlPFC 20° 1000 
lOfPFC, mOfPFC, ACC, corpus callosum, temporal 
and parietal lobes, thalamus 
VTA-mOfPFC 20° 500 
lOfPFC, dlPFC, ACC, temporal and parietal lobes, 
thalamus, Nacc 
VTA-lOfPFC 20° 500 
mOfPFC, dlPFC, temporal lobe, parietal lobe, 
thalamus, Nacc 
LC-dlPFC 20° 1000 
lOfPFC, mOfPFC, ACC, corpus callosum, temporal 
and parietal lobes, thalamus 
LC-mOfPFC 20° 500 
lOfPFC, dlPFC, ACC, temporal and parietal lobes, 
thalamus, Nacc 
LC-lOfPFC 20° 500 
mOfPFC, dlPFC, temporal and parietal lobes, 
thalamus, Nacc 
MR-Cer Lob VII 10° 1000 / 
	 2	
MR-Cer Lob V+VI 10° 1000 Cer Lob VII 
DR-Cer Lob VII 10° 1000 / 
DR-Cer Lob V+VI 10° 1000 Cer Lob VII 
Cingulum 20° 10.000 Temporal lobe, hippocampus, corpus callosum 
 
Abbreviations = VTA: ventral tegmental area; Nacc: nucleus accumbens; dlPFC: dorso-lateral prefrontal cortex; 
mOfPFC: medial orbito-frontal prefrontal cortex; lOfPFC: lateral orbito-frontal prefrontal cortex; PCC: 
posterior cingulate, cortex; ACC: anterior cingulate cortex; LC: locus coeruleus; MR: median raphe; DR: dorsal 


























Supplementary Table 2: Correlations between fibre density and cross-section (FDC) 
and fatigue scores. Correlations between FDC in the selected fibre tracts in relapsing-
remitting multiple sclerosis patients and fatigue scores, as computed by the total score of the 
Modified Fatigue Impact Scale (MFIS-Tot), which is obtained by adding the scores of the 
MFIS subscales: cognitive (MFIS-Cog), physical (MFIS-Phys) and psychosocial (not shown). 
Correlations between FDC and MFIS scores were performed assessing the Pearson 
correlation coefficient (r). Statistical threshold was set to p<0.025 after Bonferroni correction 
for multiple comparisons.  
 
Tract MFIS-Tot MFIS-Cog MFIS-Phys 
 r p r p r p 
FDC VTA-Nacc -0,19 0,126 -0,28 0,021 0,14 0,248 
FDC VTA-amygdala -0,21 0,090 -0,27 0,017 -0,03 0,796 
FDC VTA-hippocampus -0,32 0,008 -0,36 0,002 -0,05 0,662 
FDC VTA-dlPFC -0,15 0,237 -0,25 0,037 0,09 0,475 
FDC VTA-mOfPFC -0,14 0,272 -0,25 0,040 0,06 0,610 
FDC VTA-lOfPFC -0,16 0,185 -0,30 0,014 0,05 0,688 
FDC LC-dlPFC -0,16 0,180 -0,29 0,017 0,07 0,585 
FDC LC-mOfPFC -0,15 0,219 -0,26 0,031 0,04 0,773 
FDC LC-lOfPFC -0,15 0,219 -0,28 0,019 0,06 0,601 
FDC MR-Cer Lob VII -0,17 0,164 -0,27 0,025 0,21 0,084 
FDC MR-Cer Lob V+VI -0,13 0,275 -0,22 0,068 0,17 0,173 
FDC DR-Cer Lob VII -0,10 0,419 -0,14 0,244 0,18 0,146 
FDC DR-Cer Lob V+VI -0,03 0,818 -0,07 0,569 0,24 0,052 
Cingulum -0,22 0,066 -0,34 0,004 0,09 0,471 
 
[Abbreviations: MFIS: Modified Fatigue Impact Scale; Tot: total score; Cog: cognitive subscale; Phys: physical 
subscale; FDC: fibre density and cross-section; VTA: ventral tegmental area; Nacc: nucleus accumbens; dlPFC: 
dorsolateral prefrontal cortex; mOfPFC: medial orbito-frontal prefrontal cortex; lOfPFC: lateral orbito-frontal 
prefrontal cortex; LC: locus coeruleus; Cer Lob: Cerebellar Lobule; MR: median raphe; DR: dorsal raphe] 
	 4	
Supplementary Table 3: Partial correlations between fibre density and cross-section 
(FDC) and fatigue scores, controlling for depression and sleep disturbances. Partial 
correlations (controlled for the scores of Hospital Anxiety and Depression Scale [HADS-D] 
and the Epworth Sleepiness Scale [ESS]) between FDC in the selected fibre tracts in 
relapsing-remitting multiple sclerosis patients and fatigue scores, as computed by the total 
score of the Modified Fatigue Impact Scale (MFIS-Tot), which is obtained by adding the 
scores of the MFIS subscales: cognitive (MFIS-Cog), physical (MFIS-Phys) and 
psychosocial (not shown). Partial correlations between FDC and MFIS scores were 
performed assessing the Pearson correlation coefficient (r), controlling for HADS-D and 
ESS. Statistical threshold was set to p<0.025 after Bonferroni correction for multiple 
comparisons.  
 
Tract MFIS-Tot MFIS-Cog MFIS-Phys 
 r p r p r p 
FDC VTA-Nacc -0,19 0,121 -0,27 0,025 0,08 0,530 
FDC VTA-amygdala -0,21 0,088 -0,28 0,021 -0,09 0,447 
FDC VTA-hippocampus -0,32 0,008 -0,36 0,002 -0,07 0,587 
FDC VTA-dlPFC -0,15 0,240 -0,24 0,055 0,00 0,990 
FDC VTA-mOfPFC -0,14 0,271 -0,24 0,054 -0,01 0,923 
FDC VTA-lOfPFC -0,17 0,179 -0,29 0,020 -0,03 0,776 
FDC LC-dlPFC -0,17 0,170 -0,28 0,022 -0,02 0,867 
FDC LC-mOfPFC -0,16 0,198 -0,26 0,033 -0,02 0,855 
FDC LC-lOfPFC -0,16 0,204 -0,28 0,023 -0,02 0,877 
FDC MR-Cer Lob VII -0,17 0,168 -0,26 0,040 0,13 0,297 
FDC MR-Cer Lob V+VI -0,13 0,276 -0,21 0,091 0,10 0,400 
FDC DR-Cer Lob VII -0,09 0,444 -0,11 0,356 0,09 0,466 
FDC DR-Cer Lob V+VI -0,02 0,851 -0,06 0,711 0,18 0,145 
Cingulum -0,23 0,067 -0,33 0,006 0,03 0,791 
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[Abbreviations: MFIS: Modified Fatigue Impact Scale; Tot: total score; Cog: cognitive subscale; Phys: physical 
subscale; FDC: fibre density and cross-section; VTA: ventral tegmental area; Nacc: nucleus accumbens; dlPFC: 
dorsolateral prefrontal cortex; mOfPFC: medial orbito-frontal prefrontal cortex; lOfPFC: lateral orbito-frontal 
prefrontal cortex; LC: locus coeruleus; Cer Lob: Cerebellar Lobule; MR: median raphe; DR: dorsal raphe] 
 
Supplementary Fig.1: Cingulum fibre tract-specific significant FDC decreases in 
patients with multiple sclerosis (RR-MS) compared to healthy control (HC). The 
cingulum – connecting the anterior cingulate cortex with posterior cingulate cortex – is 
shown in glass brain representations using the mrview tool in MRtrix3. Differences in 
average FDC between HC and RR-MS patients in the cingulum is shown in scatter plots. 
Comparisons were tested by independent sample t-tests. The statistical threshold was set to 
p<0.003 after Bonferroni correction for multiple comparisons (FDC = fibre-density cross-













Supplementary Figure 2: Differences in regional grey matter atrophy between MS 
patients and healthy controls. Voxel-based morphometry analysis displayed significant 
grey matter loss in bilateral thalamus in MS patients, as compared to healthy controls. Results 
are reported at pFWE<0.05, corrected at peak level and are overlaid on the MNI_T1 template 
using the FSLeyes tool in FSL (P = posterior, R = right). 
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